Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
US6949245B1 · kind B1 · utility
161Cited by
92References
24Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 23, 2000 |
| Grant date | Sep 27, 2005 |
| Priority date | — |
| Expiry date | Jan 24, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/801
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present application describes humanized anti-ErbB2 antibodies and methods for treating cancer with anti-ErbB2 antibodies, such as humanized anti-ErbB2 antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.